INVO Bioscience Announces Pricing Of $4.5M Public Offering Of 1.58M Units At A Price Of $2.85/Unit
Portfolio Pulse from Happy Mohamed
INVO Bioscience, Inc. (NASDAQ:INVO) has announced the pricing of its public offering of 1.58 million units at $2.85 per unit. Each unit consists of one share of common stock and two warrants, each to purchase one share of common stock. The gross proceeds are expected to be approximately $4.5 million. The offering is expected to close on August 8, 2023.
August 04, 2023 | 3:25 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
INVO Bioscience's public offering could potentially dilute existing shareholders' equity, but it could also provide the company with additional capital for growth.
Public offerings often lead to dilution of existing shareholders' equity, which can negatively impact the stock price. However, the additional capital raised can be used for growth initiatives, which could potentially have a positive impact on the company's future performance.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100